Abstract
Anesthesiologists play an important role in caring for the multiorgan donor, both during preparation in the intensive care unit and throughout organ procurement in the operating room. As demands for organs for transplantation continue to grow, organ supply frequently fails to meet such demands. Given the limited numbers of potential donors, appropriate care of such donors is critical. Despite the fact that use of donation after cardiac death (DCD) donors has increased in recent years, brain-dead, heart-beating patients continue to represent the majority of multiorgan donors. The onset of brain death leads to progressive hemodynamic instability, endocrine and electrolyte disturbances, impaired temperature regulation, and coagulopathy. All of these effects must be anticipated and appropriately treated in order to improve donor management and organ viability.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abadie A, Gay S. The impact of presumed consent legislation on cadaveric organ donation: a cross-country study. J Health Econ. 2006;25:599–620.
Hevesi Z, Lopukhin S, Angelini G, Coursin D. Supportive care after brain death for the donor candidate. Int Anesthesiol Clin. 2006;44(3):21–33.
Lopez-Navidad A, Caballero F. For a rational approach to the critical points of the cadaveric donation process. Transplant Proc. 2001;33:795–805.
Neilson J, Mateo R, Sharma S. Donation after cardiac death and liver transplantation. Curr Opin Organ Transplant. 2007;12:220–3.
Lewis J, Peltier J, Nelson H, Snyder W, Schneider K, Steinberger D, Anderson M, Krichevsky A, Anderson J, Ellefson J, D’Alessandro A. Development of the University of Wisconsin donation after cardiac death evaluation tool. Prog Transplant. 2003;13:265–73.
Wijdick E. The diagnosis of brain death. NEJM. 2001;344:1215–21.
Beecher H, Adams R, Barger A. A definition of irreversible coma: report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. JAMA. 1968;205:337–40.
Foley D, Fernandez L, Leverson G, Chin L, Krieger N, Cooper J, Shames B, Becker Y, Odorico J, Knechtle S, Sollinger H, Kalayoglu M, D’Alessandro A. Donation after cardiac death: The University of Wisconsin experience with liver transplantation. Ann Surg. 2005;242(5):724–31.
De Vera M, Lopez-Solis R, Dvorchik I, Campos S, Morris W, Demetris A, Fontes P, Marsh J. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant. 2009;9(4):773–81.
Locke J, Segev D, Warren D, Dominici F, Simpkins C, Montgomery R. Outcomes of kidneys from donors after cardiac death: implications for allocation and preservation. Am J Transplant. 2007;7(7):1797–807.
Gelb A, Robertson K. Anaesthetic management of the brain dead for organ donation. Can J Anaesth. 1990;37(7):806–12.
Robertson K, Cook D. Perioperative management of the multiorgan donor. Anesth Analg. 1990;70:546–56.
Jaffe R, Samuels S, editors. Anesthesiologist’s manual of surgical procedures. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009.
Salim A, Vassiliu P, Velmahos G, Sava J, Murray J, Belzberg H, Asensio J, Demetriades D. The role of thyroid hormone administration in potential organ donors. Arch Surg. 2001;136:1377–80.
Odom N. Organ donation. I-Management of the multiorgan donor. BMJ. 1990;300(6739):1571–3.
Wood K, McCartney J. Management of the potential organ donor. Transplant Rev. 2007;21(4):204–18.
Phongsamran P. Critical care pharmacy in donor management. Prog Transplant. 2004;14(2):105–11.
Zaroff J, Armstrong W, Dec G, Kauffman M, Peterson T, Taylor D. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations. Circulation. 2002;106:836–41.
Rosendale J, Kauffman H, McBride M, et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation. 2003;75:482–7.
Novitzky D, Cooper D, Reichart B. Hemodynamic and metabolic responses to hormone therapy in brain-dead potential organ donors. Transplantation. 1987;43(6):852–4.
Pennefather S, Bullock R, Mantle D, Dark J. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation. 1995;59:58–62.
Goarin J, Cohen S, Riou B, et al. The effects of triiodothyronine on hemodyncamic status and cardiac function in potential heart donors. Anesth Analg. 1996;83:41–7.
Shah V. Aggressive management of multiorgan donor. Transplant Proc. 2008;40(4):1087–90.
Dimopoulou I, Tsagarakis S, Anthi A, et al. High prevalence of decreased cortisol reserve in brain-dead potential organ donors. Crit Care Med. 2003;31:1113–7.
Masson F, Thiciipe M, Gin H, Mascarel A, Angibeau R, Favarel-Garrigues J, Erny P. The endocrine pancreas in brain-dead donors a prospective study in 25 patients. Transplantation. 1993;56(2):363–7.
Fitzgerald R, Hieber C, Schweitzer E, Luo A, Oczenski W, Lackner F. Intraoperative catecholamine release in brain-dead organ donors is not suppressed by administration of fentanyl. Eur J Anesthesiol. 2003;20:952–6.
McKeown D, Bonser R, Kellum J. Management of the heartbeating brain-dead organ donor. Br J Anaesthesiol. 2012;108:96–107.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this chapter
Cite this chapter
Haft, W.A., Murray, A.W. (2017). Anesthetic Management of Donor Organ Retrieval in a Multiorgan Donor. In: Subramaniam, K., Sakai, T. (eds) Anesthesia and Perioperative Care for Organ Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6377-5_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6377-5_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-6375-1
Online ISBN: 978-1-4939-6377-5
eBook Packages: MedicineMedicine (R0)